Affiliation:
1. Fundação Oswaldo Cruz, Brasil; Fundação Oswaldo Cruz, Brasil
Abstract
Abstract Public Health Emergencies (PHE) have had repercussions on health systems on a global scale, and timely access to new health technologies is a challenge for health policy. The national regulatory authorities (NRA) play a key role in the evaluation and regulation of these technologies. The present study aims to analyze the main strategies and regulatory instruments used to deal with the challenges of regulating new technologies necessary for the health system’s effective response during a PHE. This research, based on WHO and Brazilian NRA norms and documents, considered dimensions related to strategies for strengthening regulatory activities and regulatory instruments used to accelerate access to technologies, especially during PHEs. International cooperation between the NRA and the WHO were important strategies for strengthening the NRA, with emphasis on the use of reliance, regionalization, accelerated assessments, and work/information sharing, as well as the processes of regulatory harmonization and convergence. In addition to the use of existing regulatory instruments, efforts were also identified in order to implement new ones.
Reference45 articles.
1. Do Ebola ao Zika as emergências internacionais e a securitização da saúde global;Ventura DFL;Cad Saude Publica,2016
2. Emergências de saúde pública breve histórico, conceitos e aplicações;Carmo EH;Saude Debate,2020
3. Impact of regulatory science on global public health;Patel M;Kaohsiung J Med Scie,2012
4. Medicines regulatory harmonization: international collaboration as a key to improve public health;Reggi V;J Medicine Access,2017
5. Expanding global access to essential medicines investment priorities for sustainably strengthening medical product regulatory systems;Roth L;Global Health,2018